Pan-cancer multi-omics profiling and single-cell characterization of KCNAB2 identify a proliferative blast state in acute myeloid leukemia with in vitro functional validation

Background/Objectives: KCNAB2, a voltage-gated potassium channel β-subunit, has been implicated in tumorigenesis, but its specific role in acute myeloid leukemia (AML) remains unclear. This study aimed to profile KCNAB2 across human cancers and delineate its regulatory function in AML cell proliferation and apoptosis. Methods Public databases (GEPIA2.0, UALCAN, LinkedOmics) were used to profile KCNAB2 across cancers as a background analysis (expression, copy number variation, DNA methylation, immune infiltration, tumor mutational burden, microsatellite instability, stemness and drug sensitivity), which supported the subsequent AML-focused work. KCNAB2 expression was examined at single-cell resolution in an adult AML cohort (GSE116256) and validated in an independent pediatric AML cohort (GSE154109). CCK-8, EdU and apoptosis assays assessed KCNAB2 function in AML cell lines in vitro. Results KCNAB2 was heterogeneously expressed and significantly upregulated in AML and several solid tumors. Copy number variation and DNA methylation drove its dysregulation, and expression correlated with immune infiltration and checkpoint markers. Single-cell profiling localized KCNAB2 to the malignant, progenitor-like compartment of AML in both cohorts. In the pediatric cohort, KCNAB2-positive blasts were characterized by cell-cycle and DNA-replication programs, whereas the adult cohort showed no gene-level significance and only a preliminary calcium-signaling enrichment. Knockdown of KCNAB2 significantly suppressed proliferation and induced apoptosis in AML cells. Conclusions KCNAB2 modulates proliferative and apoptotic phenotypes in AML, and its expression is associated with immune and oncogenic transcriptional programs, supporting its role as a functional regulator and a candidate therapeutic target requiring further preclinical validation.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-19
DOI
https://doi.org/10.21203/rs.3.rs-11345010/v1
Primary Topic
Acute Myeloid Leukemia Research
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Pan-cancer multi-omics profiling and single-cell characterization of KCNAB2 identify a proliferative blast state in acute myeloid leukemia with in vitro functional validation

Jianhua Zhu, Qianhe Xu, Shuhong Ke
Research Square
Acute Myeloid Leukemia Research
preprint

Pan-cancer multi-omics profiling and single-cell characterization of KCNAB2 identify a proliferative blast state in acute myeloid leukemia with in vitro functional validation

Jianhua Zhu, Qianhe Xu, Shuhong Ke
preprint en

Abstract

Background/Objectives: KCNAB2, a voltage-gated potassium channel β-subunit, has been implicated in tumorigenesis, but its specific role in acute myeloid leukemia (AML) remains unclear. This study aimed to profile KCNAB2 across human cancers and delineate its regulatory function in AML cell proliferation and apoptosis. Methods Public databases (GEPIA2.0, UALCAN, LinkedOmics) were used to profile KCNAB2 across cancers as a background analysis (expression, copy number variation, DNA methylation, immune infiltration, tumor mutational burden, microsatellite instability, stemness and drug sensitivity), which supported the subsequent AML-focused work. KCNAB2 expression was examined at single-cell resolution in an adult AML cohort (GSE116256) and validated in an independent pediatric AML cohort (GSE154109). CCK-8, EdU and apoptosis assays assessed KCNAB2 function in AML cell lines in vitro. Results KCNAB2 was heterogeneously expressed and significantly upregulated in AML and several solid tumors. Copy number variation and DNA methylation drove its dysregulation, and expression correlated with immune infiltration and checkpoint markers. Single-cell profiling localized KCNAB2 to the malignant, progenitor-like compartment of AML in both cohorts. In the pediatric cohort, KCNAB2-positive blasts were characterized by cell-cycle and DNA-replication programs, whereas the adult cohort showed no gene-level significance and only a preliminary calcium-signaling enrichment. Knockdown of KCNAB2 significantly suppressed proliferation and induced apoptosis in AML cells. Conclusions KCNAB2 modulates proliferative and apoptotic phenotypes in AML, and its expression is associated with immune and oncogenic transcriptional programs, supporting its role as a functional regulator and a candidate therapeutic target requiring further preclinical validation.

Research Square
Hubei University of Chinese Medicine (CN), Huazhong University of Science and Technology (CN)
Acute Myeloid Leukemia Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon